Early responses to intravitreal ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
about
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab.The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration.High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian populationTwo-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients.Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward.A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy.Major single nucleotide polymorphisms in polypoidal choroidal vasculopathy: a comparative analysis between Thai and other Asian populations.HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration.Visual outcome of photodynamic therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy over 5 years of follow-up.Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review.
P2860
Q34655439-5ACBDD41-F3E8-43D2-8920-762EA387DA9AQ34958682-73BE8FFC-DA04-4190-981B-D94BE3EFCA65Q35691953-F9D31E14-6CE8-4801-B7BE-DCFFC8054F70Q36750280-4F833BC8-4240-463D-A3DA-D2DB8DF73A1DQ36787782-9E8E79EA-A0D4-4901-B107-B2DCC658F825Q38582381-F2119CA0-013D-4FA2-8C1E-27B0E2513423Q39842862-93D29E25-DFCC-42DE-8E39-28FB2CC0E414Q42093957-BB789E93-6E29-4D7C-8CE8-A9C61D85671EQ42545847-80B5EFFB-457A-4D3B-904F-1F349DF757B1Q44662304-01D97DCB-4450-4176-B39A-CAA166BD7E33Q52632539-0EC65393-5764-45C5-91EC-F68A6BBDEC99
P2860
Early responses to intravitreal ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Early responses to intravitrea ...... poidal choroidal vasculopathy.
@en
type
label
Early responses to intravitrea ...... poidal choroidal vasculopathy.
@en
prefLabel
Early responses to intravitrea ...... poidal choroidal vasculopathy.
@en
P2093
P2860
P356
P1476
Early responses to intravitrea ...... ypoidal choroidal vasculopathy
@en
P2093
Akira Negi
Hiroaki Bessho
Shigeru Honda
Wataru Matsumiya
Yasutomo Tsukahara
P2860
P304
P356
10.1155/2011/742020
P577
2011-06-12T00:00:00Z